# Mayo Clinic finds TRAILshort protein acts as immune off switch that weakens CAR-T

_Published Sunday, August 9, 2026 at 4:05 PM EDT · Science · Latest · Tier 2 — Notable_

Mayo Clinic researchers report that TRAILshort functions as an immune off switch that stops T cells from attacking cancerous and virus-infected cells and weakens CAR-T therapy, SciTechDaily reported, citing the Journal of Clinical Investigation.

In preclinical models, blocking the protein restored T-cell activity. Elevated TRAILshort appeared in melanoma, lung, breast, pancreatic, and ovarian cancers and Hodgkin lymphoma, and also in COVID-19, tuberculosis, and hepatitis C. The team found TRAILshort activates SHP-1, a molecular brake that switches off T cells.

Lead author Shahrzad Jalali said the work is the first to show TRAILshort acts as a signaling molecule that directly suppresses T-cell activity, not only blocking cell death. Senior author Andrew Badley said the protein shows up across cancer and misfiring-immune conditions. Co-author Saad Kenderian said targeting it could strengthen CAR-T. Further work is needed on safety and efficacy in patients.

## Sources

- [SciTechDaily](https://scitechdaily.com/cancer-cells-exploit-a-hidden-immune-off-switch/)

---
Canonical: https://techandbusiness.org/newswire/HdPymFFSowWDtV5vqzQ_t1
Published: 2026-08-09T20:05:48.591Z
Story chronology: 2026-08-09T16:02:41.000Z
Retrieved: 2026-09-24T03:35:59.423Z
Publisher: Tech & Business (techandbusiness.org)